COMP <GO>
MNKD vs ABBV // NET PROFIT MARGIN
MannKind Corporation (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MNKD 4
— ABBV 7
▲ NET PROFIT MARGIN LEADER: ABBV
LAST: $3.50 (+2.04%) • MKT CAP: $1.13B
net-margins
1.70%
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
net-margins
6.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MNKD VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MNKD | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.30% | 70.20% | +22.10 | MNKD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 54.50% | 29.00% | +25.50 | MNKD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.6x | 33.3x | -8.70 | MNKD | /valuation <GO> |
| Free Cash Flow Yield | 1.22% | 3.47% | -2.25 | ABBV | /fcf-yield <GO> |
| Operating Margin | 11.10% | 24.60% | -13.50 | ABBV | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 1.70% | 6.90% | -5.20 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 22.20% | 8.60% | +13.60 | MNKD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.33 | -5.13 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 65.1 | -9.50 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.13B | $513.86B | -$512.73B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MNKD REV | ABBV REV | MNKD GROSS % | ABBV GROSS % | MNKD FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $349.0M | $61.16B | 92.3% | 70.2% | $13.7M | $17.82B |
| FY 2024 | $285.5M | $56.33B | 93.9% | 70.0% | $32.8M | $17.83B |
| FY 2023 | $199.0M | $54.32B | — | — | $34.1M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MNKD // BETA —
ABBV // BETA 1.15